Showing results (2171-2180 of 2,317) with videos related to
Sort By:
Pageof 232
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II StudyXiaohua Wu, Jianqing Zhu, Jing Wang, et al.Blood|March 25, 2021
YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent mannerMengdie Feng, Xueqin Xie, Guoqiang Han, et al.European Journal of Cancer (Oxford, England : 1990)|September 13, 2024
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trialMartin Reck, Tudor-Eliade Ciuleanu, Michael Schenker, et al.The Lancet. Oncology|May 1, 2019
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trialZefei Jiang, Wei Li, Xichun Hu, et al.JAMA|September 27, 2022
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical TrialYing Cheng, Liang Han, Lin Wu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2023
Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic CancerShukui Qin, Jin Li, Yuxian Bai, et al.Gastroenterology|August 13, 2013
MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patientsRuo-Yu Wang, Lei Chen, Hai-Yang Chen, et al.Annals of Surgery|July 21, 2025
Noninvasive Deep Learning System for Preoperative Diagnosis of Follicular-Like Thyroid Neoplasms Using Ultrasound Images: A Multicenter, Retrospective StudyHui Shen, Yue Huang, Wenxiao Yan, et al.Journal of Gastroenterology and Hepatology|January 5, 2020
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trialJianming Xu, Rui-Hua Xu, Shukui Qin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with ChemotherapyCaicun Zhou, Yina Wang, Jun Zhao, et al.Pageof 232